1. Artaud-Macari, E., Goven, D., Brayer, S., Hamimi, A., Besnard, V., Marchal-Somme, J., Ali, Z.E., Crestani, B., Kerdine-Römer, S., Boutten, A. & Bonay, M. (2013) Nuclear factor erythroid 2-related factor 2 nuclear translocation induces myofibroblastic dedifferentiation in idiopathic pulmonary fibrosis. Antioxid. Redox Signal., 18, 66-79.
2. Barnes, J.L. & Gorin, Y. (2011) Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases. Kidney Int., 79, 944-956.
3. Baum, J. & Duffy, H.S. (2011) Fibroblasts and myofibroblasts: what are we talking about? J. Cardiovasc. Pharmacol., 57, 376-379.
4. Border, W.A., Okuda, S., Languino, L.R., Sporn, M.B. & Ruoslahti, E. (1990) Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature, 346, 371-374.
5. Brenner, D.A. (2009) Molecular pathogenesis of liver fibrosis. Trans. Am. Clin. Climatol. Assoc., 120, 361-368.